Allele-specific expression (ASE) analysis, which quantifies the relative expression of two alleles in a 1 3 diploid individual, is a powerful tool for identifying cis-regulated gene expression variations that underlie 1 4 phenotypic differences among individuals. Existing methods for gene-level ASE detection analyze one 1 5
Genome-wide association studies (GWAS) are successful in identifying candidate loci for complex 3 3 human diseases and traits.
, 2
Despite the impressive success for disease susceptibility loci discovery, 3 4 few, if any, results from GWAS have led yet to the delivery of new therapies. 3 The association peaks 3 5 from GWAS typically identify a handful of gene candidates, but it is often unclear whether these 3 6
candidates are expressed in relevant tissues and cell types. Further complicating the picture, we now 3 7 know that most GWAS signals are probably the result of regulatory variants that impact gene 3 8 expression, rather than amino acid changes. Data on gene expression from tissues and cell types 3 9 directly involved in disease are critically important to find causative genes. 4 0 4 1 A commonly used approach to understand the functional roles of GWAS identified genetic variants is 4 2 expression quantitative trait loci (eQTL) analysis. 4 , 5
The rationale is that, a genetic variant, known as 4 3 an eQTL, influences the expression level of a gene, and differences in gene expression levels among 4 4 individuals may lead to different phenotypes. Studies have found that many GWAS identified single 4 5 nucleotide polymorphisms (SNPs) are significantly enriched for eQTLs, compared to control SNPs 4 6 matched by allele frequencies.
6 eQTL analysis identifies both cis-and trans-regulatory SNPs, in which 4 7 cis-eQTLs affect gene expression in an allele-specific manner, with implications on underlying 4 8 mechanism, whereas trans-eQTLs affect gene expression in an allele independent manner. ܺ be the read count for the reference allele in the genome, and 1 1 3 ܻ be the total read count at the SNP. Assume haplotype phase information is known, i.e., the paternal 1 1 4 and maternal alleles can be differentiated when there are more than one tSNPs of the gene. We further 1 1 5 assume the major haplotype, defined as the haplotype that resides with the R allele of the rSNP which 1 1 6 has higher expression than the other haplotype, is known, and ‫ܯ‬ is the read count for the 1 1 7 corresponding allele that resides on the major haplotype. 
‫ܯ‬
The random effect, ߛ , represents the individual-specific true underlying transcript frequency of the 1 2 5 major haplotype on a logarithmic scale, whose distribution is assumed to be a mixture of two unknown 1 2 6 In the above framework, we have assumed the haplotype phase is known and the major allele can be 1 4 2 inferred. However, in real studies, the haplotype phase is often unknown and the observed data offer 1 4 3 little or no information of which allele is the major allele. In the absence of DNA genotype data, with 1 4 4 only the ܺ and ܻ of the tSNP, it is challenging to infer which alleles at different SNPs reside on the 1 4 5 same haplotype. Even when haplotype phase is known, lacking information of the rSNP, makes it 1 4 6 difficult to align read counts across individuals as we do not know which allele resides on the same 1 4 7 haplotype with the R allele. To overcome the above-mentioned challenges and determine the major 1 4 8 allele, we adapted a pseudo phasing procedure, originally employed by MBASED. This procedure 1 4 9 uses a 'majority voting' approach based on observed read counts. For each individual, when the 1 5 0 haplotype phase information is known, we assign the haplotype with larger total reads, obtained by 1 5 1 summing up read counts across all SNPs on the same haplotype, as the major haplotype. When 1 5 2 haplotype phase is unknown, we assign the allele with larger read counts of each SNP to the major 1 5 3 haplotype, and alleles on the inferred major haplotype are treated as major alleles. 1 5 4 1 5 5
Detection of differential ASE between two conditions 1 5 6
The previously described ASE detection procedure for one condition can be naturally extended to 1 5 7 detect gene-level ASE difference between two conditions (e.g., conditions A and B) using paired RNA-1 5 8 seq data, where the same individual is sequenced under both conditions. Similar to the one condition 1 5 9 
Here ߛ represents ܲ on the logarithmic scale whose conditional distribution is assumed to be a 1 6 7 mixture of two unknown distributions, with transcript frequency between the two conditions, for 'Hom' and 'Het' individuals, respectively. Similarly, 1 7 0 parameters are estimated using the NPML approach. To test gene-level ASE difference between 1 7 1 two conditions, we consider the following hypothesis: Similar to the one condition analysis, the haplotype phase and major haplotype information are often 1 7 4 unknown in real studies. Again, we employ the pseudo phasing procedure to differentiate the major 1 7 5 haplotype and align them across individuals.
1 4
To ensure that major haplotypes are identical for the 1 7 6 same individual under different conditions, we choose one condition as 'reference', obtain its phasing 1 7 7 information, and phase the data from the other condition accordingly. Ideally, to improve the phasing 1 7 8 accuracy, the condition with larger ASE effect is preferred to be used as the 'reference'. 1 7 9
We consider
as the test statistic and assess its significance through resampling. To 1 8 0 
‫‬
, as the pooled major allele frequency, will always be larger 1 8 7 than 0
. 5
, which violates our assumption of no ASE effect under both conditions. To make the 1 8 8 resampled data represent the null, as a second step, ‫‬ is obtained through a weighted sum as the 1 8 9 following: number of tSNPs (2, 4 or 6). For each individual, we generated the data with a pre-specified minor 1 9 8 allele frequency ‫)ܨܣܯ(‬ of the rSNP (0.1, 0.3 or 0.5), and assigned 'Hom' or 'Het' based on the 1 9 9
genotype of the rSNP. The haplo-genotype data were simulated assuming Hardy-Weinberg equilibrium 2 0 0 (HWE) with assigned haplotype frequencies so that, for each tSNP, Tube were cultured in macrophage culture media, 20% FBS in RPMI 1640 media with 100 ng/ml 2 2 8 human macrophage colony-stimulating factor (M-CSF), for 7 days on BD Primaria TM tissue culture plate 2 2 9 to induce macrophage differentiation.(PMID: 25904599 ) by batches and the samples were 2 3 6 randomly assigned to each batch. The RNA quality and quantity were determined by Agilent 2100 2 3 7
Bioanalyzer (Median RIN = 7.9, n = 96 samples from 48 subjects). With a minimum of 300 ng input 2 3 8 RNA, libraries were prepared using the TruSeq RNA Sample Preparation Kit (Illumina, San Diego, CA), We evaluated the performance of ASEP to detect gene-level ASE under one condition across a wide 2 4 6 range of scenarios. We first considered the situation when phase among the tSNPs is known. Our 2 4 7 simulations showed that type I error rate was controlled at the 5% level under all scenarios we 2 4 8 investigated. As expected, the power of ASEP increases as the number of individuals, sequencing 2 4 9 depth, or the number of heterozygous tSNPs increases. Among these three factors, the sequencing 2 5 0 depth is the most influential one as compared to the other two. In addition, the magnitude of power 2 5 1 increase for a specific factor depends on the values of the other factors. For example, the effect of 2 5 2 sequencing depth or sample size is minimal until the number of tSNPs increases from 2 to 4, and the 2 5 3 effect becomes much stronger when the number of tSNPs increases further to 6. With large sample 2 5 4 size, high sequencing depth and more tSNPs, our method has sufficient power to detect ASE effect that 2 5 5 is as small as 0.05. Further, increasing the proportion of 'Het' individuals in the sample, determined by 2 5 6 leading to larger effective sample size in detecting ASE (Figure 2A and Figure S1A ). 2 6 1 2 6 2 Next, we examined the performance of ASEP when haplotype phase is unknown. The type I error rate 2 6 3 was still under control across all scenarios considered. For power evaluation, due to potential phasing 2 6 4 errors caused by separating paternal and maternal alleles, we increased the true underlying ASE effect 2 6 5 from 0.55 to 0.6 in order to have adequate detection power. As expected, the read depth is still the 2 6 6 most important factor as compared to sample size and the number of tSNPs. Additionally, increasing 2 6 7 the proportion of 'Het' individuals leads to improved power under all scenarios, similar to what we 2 6 8 observed for phase known situation (Figure 2B and Figure S1B ). 2 6 9 2 7 0 Detecting differential ASE between two conditions 2 7 1
We then evaluated the performance of ASEP to detect ASE difference between two conditions. When 2 7 2 haplotype phase information is known, the type I error rate of ASEP was well controlled across a variety 2 7 3 of settings. Similar to the one condition analysis, when MAF of the rSNP is fixed, the power increased 2 7 4 as the number of individuals, sequencing depth, or the number of tSNPs increased. Among these three 2 7 5 factors, read depth had the largest impact on power. Moreover, a specific factor only had minor impact 2 7 6 on power when the other two factors were at low level. When any two of the three factors were at high 2 7 7 level, ASEP had adequate power to detect a 0.05 ASE difference between two conditions. However, 2 7 8 unlike one condition analysis, increasing ‫ܯ‬ ‫ܣ‬ ‫ܨ‬ of the rSNP did not necessarily improve the model 2 7 9 performance for detecting differential ASE between two conditions. In fact, its effect depended on the 2 8 0 value of the three aforementioned factors. Power increased with
‫ܯ‬
‫ܣ‬ ‫ܨ‬ only when number of tSNPs are 2 8 1 high or number of tSNPs are moderate but with high sequencing depth (Figure 3A and Figure S2A ). Application to a human macrophage RNA-seq dataset 2 9 5
We applied ASEP to a paired macrophage RNA-seq dataset generated from 48 healthy individuals 2 9 6 ( Supplementary Table S5 for subject demographics). Human PBMC can be cultured and differentiated 2 9 7 to macrophages, and polarized in vitro to functionally and molecularly distinct M1-like inflammatory 2 9 8 macrophages by IFN-γ and LPS, an important and widely-used experimental model to study 2 9 9 macrophage biology in homeostasis and diseases (PMID: 26982353 2 0 , 30679807 2 1
). M0 and M1 3 0 0 macrophages from each individual were subject to 2x101 bp paired-end RNA-seq. Reads were aligned 3 0 1 to human genome hg19 using STAR 2.6.0a 2 2
. Reads from each pair were required to map to the same 3 0 2 chromosome with distance <500,000 bp. Only uniquely mapped reads were retained for downstream 3 0 3 analysis. The RNA-seq data were processed using WASP 2 3
to remove the possible mapping bias and 3 0 4 extract allele-specific read counts. 3 0 5 3 0 6
We first applied ASEP for one condition analysis to M0 and M1 macrophage samples separately to 3 0 7 detect ASE genes under each condition. For a given gene, a tSNP is included in the analysis if the 3 0 8 minor allele count 5, total read depth 20, and the minor allele count is at least 5% of the total read 3 0 9 count. Genes that appeared in less than three individuals were excluded from analysis. In total, we 3 1 0 analyzed 5,961 genes for the M0 samples and 5,465 genes for the M1 samples, with 4,783 genes 3 1 1 common in both samples. We identified 792 genes with significant ASE (P < 0.05) in M0 and 747 genes 3 1 2 in M1. Among these genes, 634 were detected only in M0, with 124 of them not expressed in M1, and 3 1 3 589 genes detected only in M1, with 102 of them not expressed in M0. Additionally, 158 genes were 3 1 4 found to show ASE under both conditions. After multiple testing adjustment with false discovery rate 3 1 5 (FDR), 160 genes remained significant (adjusted P < 0.05) in M0 and 219 genes in M1 (Tables S1 and 3 1 6 S2). Additionally, 141 genes were detected only in M0 with 16 of them not expressed in M1, 200 genes 3 1 7 were detected only in M1 with 28 of them not expressed in M0, and 19 genes were found to have ASE 3 1 8 under both conditions (Figure 4A) . For those significant genes, we further performed gene set 3 1 9 enrichment analysis using metascape. ASE genes detected in M0 are enriched for genes related to 3 2 0 adaptive immune system and autophagy, whereas those detected in M1 are enriched for genes related 3 2 1 to cytokine signaling in immune system and cellular responses to external stimuli (Figure 5A) . 3 2 2 3 2 3
Encouraged by the above analysis results, we next performed the differential ASE analysis between M0 3 2 4 and M1 by selecting 924 candidate genes from one condition analysis that were found to show 3 2 5 evidence of ASE (P < 0.05) in M0 or M1. Since haplotype phase is unknown, to reduce phasing error, 3 2 6
for each gene, we chose the condition with higher estimated ASE effect as the 'reference' to phase the 3 2 7 data from the other condition. In total, we detected 190 genes showing evidence of differential ASE (P 3 2 8 < 0.05), with 96 genes still being significant after multiple testing adjustment (FDR adjusted P < 0.05) 3 2 9
( Figure 4B and Table S3 ). We performed enrichment analysis for these 96 genes, and as expected, 3 3 0 these differential ASE genes are highly enriched for leukocyte activation involved in immune response 3 3 1 ( Figure 5B) . 3 3 2 3 3 3
Since macrophages are important regulators and promoters of many cardiovascular disease programs, 3 3 4 next, we examined whether these 96 genes showing significant differential ASE overlap with findings 3 3 5 from GWAS for cardiovascular disease (CVD), coronary artery disease (CAD), and acute coronary 3 3 6 syndrome (ACS).
5
Among the 96 genes, 52 overlapped with loci that reached GWAS significance 3 3 7 ሺ ܲ ൏ 5 ൈ 1 0 ି ଼ ሻ (Table S4) . For example, PECAM1 showed strong evidence of differential ASE (FDR 3 3 8 adjusted P < 0.0001). A previous study showed that PECAM1 is up-regulated by LPS stimulation, and 3 3 9 may function as a feedback negative regulator of inflammatory response in macrophages.
6
Figure 6 3 4 0 shows the estimated SNP-level ASE difference for each individual, i.e., the difference in major allele 3 4 1 proportion of each SNP after haplotype phasing between M1 and M0 samples for each individual. After 3 4 2 sorting individuals by their median of estimated ASE difference among heterozygous SNPs, we 3 4 3 observed that, majority of the individuals have positive ASE difference with a few having negative ASE 3 4 4 difference, which might be due to potential phasing uncertainty. About one-third of the subjects have 3 4 5 median ASE difference around zero, which presumably are individuals with homozygous cis-regulatory 3 4 6 SNP. However, since more individuals have positive ASE difference, our method was able to detect 3 4 7 evidence of differential ASE at the population level by aggregating information across individuals and 3 4 8 transcribed SNPs (Figure 6A ). 3 4 9 3 5 0
We also detected differential ASE in CXCL16 (FDR adjusted P = 0.0007) in the macrophage data, 3 5 1 which has been reported to play a critical role on inflammation. CXCL16 acts as a scavenger receptor 3 5 2 and promotes the uptake of modified lipids that leads to foam cell formation.
7
Lehrke et al. showed 3 5 3 that CXCL16 may associate with human atherosclerosis, and is correlated with inflammatory and 3 5 4 metabolic response of acute coronary syndrome.
5
Our RNA-seq data suggest that approximately half 3 5 5 of the subjects have estimated ASE difference around zero, whereas the other half have ASE 3 5 6 difference deviating considerably from zero. By accounting for sample heterogeneity, ASEP was able to 3 5 7 uncover differential ASE between conditions (Figure 6B ). 3 5 8
